DCF — PALOMAR MEDICAL CENTER POWAY
Enterprise Value: $-140.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-140.7M
Enterprise Value
$-48.6M
PV of Cash Flows
$-92.1M
PV of Terminal Value
$-148.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $210.1M | $-6.5M | -3.0% | $-15.4M | $-14.0M |
| Year 2 | $216.4M | $-4.6M | -2.0% | $-13.7M | $-11.3M |
| Year 3 | $222.9M | $-2.5M | -1.0% | $-11.9M | $-8.9M |
| Year 4 | $229.5M | $-1.4M | -1.0% | $-11.1M | $-7.6M |
| Year 5 | $236.4M | $-0.8M | -0.0% | $-10.9M | $-6.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-140.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$203.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03607207985954339
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5